Evaluating Excipient Safety in Pediatric Populations: Current Thinking from a Bioequivalence Perspective August 8, 2024

https://www.fda.gov/drugs/news-events-human-drugs/evaluating-excipient-safety-pediatric-populations-current-thinking-bioequivalence-perspective?utm_medium=email&utm_source=govdelivery#event-information This webinar is hosted by the Food and Drug Administration (FDA), in collaboration with the American Association of Pharmaceutical Scientists (AAPS) and will explore the latest thinking and practices in evaluating excipient safety for pediatric populations, with a focus on bioequivalence assessment for generic drugs. Join our expert speakers as they: Share the latest developments in excipient safety evaluation for pediatric populations, Discuss the critical role of risk-based approaches in bioequivalence assessment, and Present real-world case studies highlighting challenges and opportunities in ensuring excipient safety By attending, you'll gain valuable insights and practical takeaways to enhance your work in ensuring the safety and well-being of pediatric patients.